The Food and Drug Administration (FDA) currently recognizes hyperbaric oxygen therapy (HBOT) for 14 conditions, all of which are generally covered by insurance.
HBOT may have benefits for other conditions not yet approved by the FDA. Many of those conditions have undergone significant research, especially in other countries. A list of FDA-approved conditions and certain others than have not yet gained FDA approval are available below.
We strive to maintain an active database of research on HBOT. For each condition listed below, click the button to view the research we have on file. We are continually updating this database as new research becomes available; so please check back for updates. If you have any questions regarding any of the research, or if you would like more information about any of the conditions listed, please click here.
Treatment for conditions not yet approved by the FDA is generally not covered by insurance and is not available at hospital-based hyperbaric centers. Our policy at HMS is to accommodate the needs and circumstances of any patient whom our physicians believe would benefit from HBOT. Several payment options and financial assistance programs are available.
Click here to read A Systematic Review of the Literature Reporting The Application of Hyperbaric Oxygen To the Prevention and Treatment Of Delayed Radiation Injuries
Click here to read Hyperbaric Oxygen Therapy for Alzheimer’s Dementia with Positron Emission Tomography Imaging: A Case Report